Trillium Therapeutics Inc.
$965,000.00
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
Federal Economic Development Department for Ontario
EF 2011-2012
Canada
Trillium Therapeutics is a biotechnology company specializing in innovative therapies of immunology and ctyoprotection. Funds will help commercialize a therapeutic treatment for interstitial cystitis.